1, 4-Dióxido de quinoxalina; Una opción viable para el desarrollo de fármacos antituberculosos

Isidro Palos; Gildardo Rivera

1, 4-Dióxido de quinoxalina; Una opción viable para el desarrollo de fármacos antituberculosos

Isidro Palos, Gildardo Rivera

Centro de Biotecnología Genómica (CBG)

Producción científica: Contribución a una revista › Artículo de revisión › revisión exhaustiva

1 Cita (Scopus)

Resumen

Tuberculosis is a major infectious disease in the world, which causes high mortality. The treatment consists of drugs of first and second line; however, its effectiveness is limited by several factors, mainly the presence of resistant and/or multi-drug resistant strains. This work reviews compounds derived from quinoxaline 1, 4-dioxide with antimycobacterial activity in in vitro and in vivo models as an option for the development of new drugs against tuberculosis.

Título traducido de la contribución	Quinoxaline 1,4-dioxide: A viable option for the development of antitubercular drugs
Idioma original	Español
Páginas (desde-hasta)	17-23
Número de páginas	7
Publicación	Revista Mexicana de Ciencias Farmaceuticas
Volumen	46
N.º	2
Estado	Publicada - 1 abr. 2015

Palabras clave

Drugs
Quinoxaline 1,4-dioxide
Tuberculosis

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{e678a1df2190445fa2cf0c2e44b342a0,

title = "1, 4-Di{\'o}xido de quinoxalina; Una opci{\'o}n viable para el desarrollo de f{\'a}rmacos antituberculosos",

abstract = "Tuberculosis is a major infectious disease in the world, which causes high mortality. The treatment consists of drugs of first and second line; however, its effectiveness is limited by several factors, mainly the presence of resistant and/or multi-drug resistant strains. This work reviews compounds derived from quinoxaline 1, 4-dioxide with antimycobacterial activity in in vitro and in vivo models as an option for the development of new drugs against tuberculosis.",

keywords = "Drugs, Quinoxaline 1,4-dioxide, Tuberculosis",

author = "Isidro Palos and Gildardo Rivera",

year = "2015",

month = apr,

day = "1",

language = "Espa{\~n}ol",

volume = "46",

pages = "17--23",

journal = "Revista Mexicana de Ciencias Farmaceuticas",

issn = "1027-3956",

number = "2",

}

TY - JOUR

T1 - 1, 4-Dióxido de quinoxalina; Una opción viable para el desarrollo de fármacos antituberculosos

AU - Palos, Isidro

AU - Rivera, Gildardo

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Tuberculosis is a major infectious disease in the world, which causes high mortality. The treatment consists of drugs of first and second line; however, its effectiveness is limited by several factors, mainly the presence of resistant and/or multi-drug resistant strains. This work reviews compounds derived from quinoxaline 1, 4-dioxide with antimycobacterial activity in in vitro and in vivo models as an option for the development of new drugs against tuberculosis.

AB - Tuberculosis is a major infectious disease in the world, which causes high mortality. The treatment consists of drugs of first and second line; however, its effectiveness is limited by several factors, mainly the presence of resistant and/or multi-drug resistant strains. This work reviews compounds derived from quinoxaline 1, 4-dioxide with antimycobacterial activity in in vitro and in vivo models as an option for the development of new drugs against tuberculosis.

KW - Drugs

KW - Quinoxaline 1,4-dioxide

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84994716222&partnerID=8YFLogxK

M3 - Artículo de revisión

SN - 1027-3956

VL - 46

SP - 17

EP - 23

JO - Revista Mexicana de Ciencias Farmaceuticas

JF - Revista Mexicana de Ciencias Farmaceuticas

IS - 2

ER -

1, 4-Dióxido de quinoxalina; Una opción viable para el desarrollo de fármacos antituberculosos

Resumen

Palabras clave

Otros archivos y enlaces

Huella

Citar esto